-
Je něco špatně v tomto záznamu ?
Elevated homocysteine levels: What inborn errors of metabolism might we be missing
A. Gonzalez, GH. Smith, MJ. Gambello, J. Sokolová, V. Kožich, H. Li
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
36271828
DOI
10.1002/ajmg.a.63001
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- homocystein MeSH
- homocystinurie * diagnóza genetika MeSH
- hyperhomocysteinemie * diagnóza genetika MeSH
- kyselina listová MeSH
- lidé MeSH
- retrospektivní studie MeSH
- vitamin B 12 terapeutické užití MeSH
- vrozené poruchy metabolismu * diagnóza genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Elevated total plasma homocysteine (hyperhomocysteinemia) is a marker of cardiovascular, thrombotic, and neuropsychological disease. It has multiple causes, including the common nutritional vitamin B12 or folate deficiency. However, some rare but treatable, inborn errors of metabolism (IEM) characterized by hyperhomocysteinemia can be missed due to variable presentations and the lack of awareness. The aim of this study is to identify undiagnosed IEM in adults with significantly elevated homocysteine using key existing clinical data points, then IEM specific treatment can be offered to improve outcome. We conducted a retrospective study with data mining and chart review of patients with plasma total homocysteine >30 μmol/L over a two-year period. We offer biochemical and genetic testing to patients with significant hyperhomocysteinemia without a clear explanation to diagnose IEM. We identified 22 subjects with significant hyperhomocysteinemia but no clear explanation. Subsequently, we offered genetic testing to seven patients and diagnosed one patient with classic homocystinuria due to cystathionine beta-synthase deficiency. With treatment, she lowered her plasma homocysteine and improved her health. This study stresses the importance of a thorough investigation of hyperhomocysteinemia in adults to identify rare but treatable IEM. We propose a metabolic evaluation algorithm for elevated homocysteine levels.
Department of Human Genetics Emory University School of Medicine Atlanta Georgia USA
Department of Pathology Emory University Emory University School of Medicine Atlanta Georgia USA
Department of Pediatrics Emory University School of Medicine Atlanta Georgia USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032050
- 003
- CZ-PrNML
- 005
- 20230131151242.0
- 007
- ta
- 008
- 230120s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ajmg.a.63001 $2 doi
- 035 __
- $a (PubMed)36271828
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gonzalez, Aixa $u Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA $u Department of Pediatrics, Genetics Section, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas, USA
- 245 10
- $a Elevated homocysteine levels: What inborn errors of metabolism might we be missing / $c A. Gonzalez, GH. Smith, MJ. Gambello, J. Sokolová, V. Kožich, H. Li
- 520 9_
- $a Elevated total plasma homocysteine (hyperhomocysteinemia) is a marker of cardiovascular, thrombotic, and neuropsychological disease. It has multiple causes, including the common nutritional vitamin B12 or folate deficiency. However, some rare but treatable, inborn errors of metabolism (IEM) characterized by hyperhomocysteinemia can be missed due to variable presentations and the lack of awareness. The aim of this study is to identify undiagnosed IEM in adults with significantly elevated homocysteine using key existing clinical data points, then IEM specific treatment can be offered to improve outcome. We conducted a retrospective study with data mining and chart review of patients with plasma total homocysteine >30 μmol/L over a two-year period. We offer biochemical and genetic testing to patients with significant hyperhomocysteinemia without a clear explanation to diagnose IEM. We identified 22 subjects with significant hyperhomocysteinemia but no clear explanation. Subsequently, we offered genetic testing to seven patients and diagnosed one patient with classic homocystinuria due to cystathionine beta-synthase deficiency. With treatment, she lowered her plasma homocysteine and improved her health. This study stresses the importance of a thorough investigation of hyperhomocysteinemia in adults to identify rare but treatable IEM. We propose a metabolic evaluation algorithm for elevated homocysteine levels.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a kyselina listová $7 D005492
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a vitamin B 12 $x terapeutické užití $7 D014805
- 650 12
- $a hyperhomocysteinemie $x diagnóza $x genetika $7 D020138
- 650 12
- $a homocystinurie $x diagnóza $x genetika $7 D006712
- 650 12
- $a vrozené poruchy metabolismu $x diagnóza $x genetika $7 D008661
- 650 _2
- $a homocystein $7 D006710
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Smith, Geoffrey Hughes $u Department of Pathology, Emory University, Emory University School of Medicine, Atlanta, Georgia, USA
- 700 1_
- $a Gambello, Michael J $u Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA $u Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
- 700 1_
- $a Sokolová, Jitka $u Department of Pediatrics and Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Kožich, Viktor $u Department of Pediatrics and Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Li, Hong $u Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA $u Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA $1 https://orcid.org/0000000293670761
- 773 0_
- $w MED00012678 $t American journal of medical genetics. Part A $x 1552-4833 $g Roč. 191, č. 1 (2023), s. 130-134
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36271828 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151238 $b ABA008
- 999 __
- $a ok $b bmc $g 1891055 $s 1183385
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 191 $c 1 $d 130-134 $e 20221022 $i 1552-4833 $m American journal of medical genetics. Part A $n Am J Med Genet $x MED00012678
- LZP __
- $a Pubmed-20230120